HIMS
Hims & Hers Health, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
29.67
close · 2026-10-29
value
8
cheaper than peers8
quality
17
stronger fundamentals17
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 3.10× | 42 |
| EV to EBITDA | 92.22× | 13 |
| price to book | 21.36× | 13 |
| forward P/E | 40.24× | 5 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | -2.7% | 49 |
| revenue growth | 3.8% | 39 |
| operating margin | -7.9% | 29 |
| debt to equity | 253.7% | 21 |
4 of 4 measures available
Facts
| market cap | $7B |
| free cash flow | $174.3M |
| employees | 2,442 |
| first trade | 2019-09-13 |
| next earnings | 2026-11-09 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 | 2021 |
| diluted eps | 0.51 | 0.53 | -0.11 | -0.32 | not reported |
| free cash flow | $57.4M | $198.3M | $47.0M | -$33.8M | not reported |
| net income | $128.4M | $126.0M | -$23.5M | -$65.7M | not reported |
| revenue | $2.35B | $1.48B | $872.0M | $526.9M | not reported |
| unusual items | $4.4M | not reported | not reported | $70,000 | $3.8M |